Costos

Marine PhytoPlankton (alPha 3 CMP)
Progress rePort froM the DireCtor of researCh life enriChMent researCh founDation
A pilot study was contracted with the Department of Health Promotion andEducation at the University of Utah to conduct clinical studies to determine the impact of Alpha 3 concentrated marine phytoplankton on human health indicators of apparently healthy individuals. Asymptomatichealthy individuals were randomly assigned to one of four treatment groups. One group took the recommended dosages of concentrated marine phytoplankton in liquid form, another group took the powderform, a third group had a placebo, and a fourth group did not take anything. This double blind study was conducted over a threemonth period using a repeated measures design—that is they were clinicallytest three times over the three months and tested five times with psychospiritual health assessment tools. Several of the indicators showed no statistically significant changes. Three markers didshow significant results. When comparing the combined liquid and powder forms of Alpha 3 CMP with both the placebo group and the control groups there was a significant difference in the CD3 complex andtwo of the emotional tests. We can make the following statements in regards to the pilot study. 1. Those that took Alpha 3 CMP showed a significant (p< .01) increase in the CD3 measures. CD3 is anindicator of the presence of T-Lymphocytes. T-Lymphocytes are primarily responsible for the elimination of internally manufactured antigens (viruses, bacteria, etc.) in organic tissues. 2. Those that tookAlpha 3 CMP showed a significant (p< .05) in scores on the emotional subscale of the SF36. The SF36 is health survey used by many in the medical community to determine functional health andwell-being. The emotional items that showed significance were favorable responses to inquiries about how they felt in the previous four weeks. Some examples are shown below: a. Feeling full of life b....